Streptococcus pneumoniae vaccine serotype persistence following 13-valent pneumococcal conjugate vaccine introduction in Mongolia: investigating changes in epidemiology, immunology and virulence
Authors:
- Paige SkokoPSPaige Skoko
- Sam MannaSMSam Manna
- Laura K. BoelsenLBLaura K. Boelsen
- Jason HindsJHJason Hinds
- Stephanie W. LoSLStephanie W. Lo
- Casey L. PellCPCasey L. Pell
- Belinda D. OrtikaBOBelinda D. Ortika
- Rachel A. HigginsRHRachel A. Higgins
- Vicki Bennett-WoodVBVicki Bennett-Wood
- Hanwen HouHHHanwen Hou
- Odgerel TundevOTOdgerel Tundev
- Eileen M. DunneEDEileen M. Dunne
Preprint
Abstract
Background: Streptococcus pneumoniae is a leading cause of pneumonia globally. Vaccine serotypes can persist despite pneumococcal conjugate vaccine (PCV) introduction. To examine serotype persistence, we leveraged 6,545 nasopharyngeal swabs collected from children hospitalised with pneumonia before and after PCV13 introduction in Mongolia and undertook molecular, epidemiological and experimental analyses. Methods: Serotype, genetic lineage and antimicrobial resistance genes were inferred from DNA microarray. Patients carrying lineages that were predominant pre- and post-PCV introduction were examined for differences in disease severity. We also compared the pre- and post-PCV lineages by bacterial adhesion to hydrocarbon (BATH) and enzyme-linked immunosorbent (ELISA) assays. Capsule gene expression was measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR), capsule thickness by transmission electron microscopy, and virulence using an infant mouse model. Findings: Changes in lineage composition were observed within serotypes 6A, 6B, 14, 19F and 23F over the six-year surveillance period. Children carrying pre-PCV lineages were more likely to have severe pneumonia than those carrying post-PCV lineages (serotypes 6B, 14 and 19F). Pre-PCV lineages were more likely to be multi-drug resistant than post-PCV lineages (serotypes 6A, 6B and 23F). For serotype 6B the post-PCV lineage had higher cell surface hydrophobicity, lower IgG, lower expression of capsule genes and evidence of thinner capsule than the pre-PCV lineage. Notably, the post-PCV 6B lineage was also less virulent in mice than the pre-PCV 6B lineage. Interpretation: Despite persistence of vaccine serotypes in highly vaccinated populations, vaccination may select for lineages with differences in capsule and antibody binding and that are less virulent. When evaluating the true value of vaccination, it is important to consider factors beyond serotype alone. Funding: National Health and Medical Research Council, Murdoch Children’s Research Institute, GAVI, the Vaccine Alliance.Keywords
This publication has 20 references indexed in Scilit:
- Effect of pneumococcal conjugate vaccination on pneumococcal carriage in hospitalised children aged 2–59 months in Mongolia: an active pneumonia surveillance programmeThe Lancet Microbe, 2024
- Effect of pneumococcal conjugate vaccine six years post-introduction on pneumococcal carriage in Ulaanbaatar, MongoliaNature Communications, 2024
- The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban MalawiNature Communications, 2023
- High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in MalawiNature Communications, 2020
- Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15The Lancet Global Health, 2018
- Streptococcus pneumoniae: transmission, colonization and invasionNature Reviews Microbiology, 2018
- No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccineJournal of Allergy and Clinical Immunology, 2016
- Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: Updated recommendations from the World Health Organization Pneumococcal Carriage Working GroupVaccine, 2013
- Serotype replacement in disease after pneumococcal vaccinationThe Lancet, 2011
- Paraformaldehyde effect on ruthenium red and lysine preservation and staining of the staphylococcal glycocalyxMicroscopy Research and Technique, 1997